Nasdaq Etf Market Value

IBB
 Etf
  

USD 122.81  2.64  2.20%   

Nasdaq Biotechnology's market value is the price at which a share of Nasdaq Biotechnology stock trades on a public exchange. It measures the collective expectations of Nasdaq Biotechnology Ishares investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Nasdaq Biotechnology Ishares and determine expected loss or profit from investing in Nasdaq Biotechnology over a given investment horizon. Please see Nasdaq Biotechnology Hype Analysis, Nasdaq Biotechnology Correlation, Portfolio Optimization, Nasdaq Biotechnology Volatility, as well as analyze Nasdaq Biotechnology Alpha and Beta and Nasdaq Biotechnology Performance.
Symbol
Backtest

The market value of Nasdaq Biotechnology is measured differently than its book value, which is the value of Nasdaq that is recorded on the company's balance sheet. Investors also form their own opinion of Nasdaq Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Nasdaq Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nasdaq Biotechnology's market value can be influenced by many factors that don't directly affect Nasdaq Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nasdaq Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine Nasdaq Biotechnology value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nasdaq Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Nasdaq Biotechnology 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nasdaq Biotechnology's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nasdaq Biotechnology.
0.00
07/10/2021
No Change 0.00  0.0 
In 11 months and 27 days
07/05/2022
0.00
If you would invest  0.00  in Nasdaq Biotechnology on July 10, 2021 and sell it all today you would earn a total of 0.00 from holding Nasdaq Biotechnology Ishares or generate 0.0% return on investment in Nasdaq Biotechnology over 360 days. The fund generally will invest at least 80 percent of its assets in the component securities of its index and in investm...More

Nasdaq Biotechnology Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nasdaq Biotechnology's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nasdaq Biotechnology Ishares upside and downside potential and time the market with a certain degree of confidence.

Nasdaq Biotechnology Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Nasdaq Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nasdaq Biotechnology's standard deviation. In reality, there are many statistical measures that can use Nasdaq Biotechnology historical prices to predict the future Nasdaq Biotechnology's volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Nasdaq Biotechnology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Nasdaq Biotechnology in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
117.95120.17122.39
Details
Intrinsic
Valuation
LowReal ValueHigh
117.87120.09122.31
Details
Naive
Forecast
LowNext ValueHigh
126.12128.35130.57
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
105.55114.72123.89
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Nasdaq Biotechnology. Your research has to be compared to or analyzed against Nasdaq Biotechnology's peers to derive any actionable benefits. When done correctly, Nasdaq Biotechnology's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Nasdaq Biotechnology.

Nasdaq Biotechnology Backtested Returns

Nasdaq Biotechnology has Sharpe Ratio of -0.0441, which conveys that the entity had -0.0441% of return per unit of risk over the last 3 months. Macroaxis standpoint towards estimating the risk of any etf is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Nasdaq Biotechnology exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to verify Nasdaq Biotechnology Ishares mean deviation of 1.78, and Risk Adjusted Performance of (0.08) to check out the risk estimate we provide.
The etf secures a Beta (Market Risk) of 1.1286, which conveys a somewhat significant risk relative to the market. Let's try to break down what Nasdaq's beta means in this case. Nasdaq Biotechnology returns are very sensitive to returns on the market. As the market goes up or down, Nasdaq Biotechnology is expected to follow. Even though it is essential to pay attention to Nasdaq Biotechnology price patterns, it is always good to be careful when utilizing equity historical price patterns. Our philosophy towards estimating any etf's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Nasdaq Biotechnology exposes twenty-eight different technical indicators, which can help you to evaluate its performance.

Auto-correlation

    
  0.48  

Average predictability

Nasdaq Biotechnology Ishares has average predictability. Overlapping area represents the amount of predictability between Nasdaq Biotechnology time series from 10th of July 2021 to 6th of January 2022 and 6th of January 2022 to 5th of July 2022. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nasdaq Biotechnology price movement. The serial correlation of 0.48 indicates that about 48.0% of current Nasdaq Biotechnology price fluctuation can be explain by its past prices.
Correlation Coefficient0.48
Spearman Rank Test0.65
Residual Average0.0
Price Variance73.7

Nasdaq Biotechnology lagged returns against current returns

Autocorrelation, which is Nasdaq Biotechnology etf's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Nasdaq Biotechnology's etf expected returns. We can calculate the autocorrelation of Nasdaq Biotechnology returns to help us make a trade decision. For example, suppose you find that Nasdaq Biotechnology etf has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
 Current and Lagged Values 
Share
      Timeline 

Nasdaq Biotechnology regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Nasdaq Biotechnology etf is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Nasdaq Biotechnology etf is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Nasdaq Biotechnology etf over time.
 Current vs Lagged Prices 
Share
      Timeline 

Nasdaq Biotechnology Lagged Returns

When evaluating Nasdaq Biotechnology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Nasdaq Biotechnology etf have on its future price. Nasdaq Biotechnology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Nasdaq Biotechnology autocorrelation shows the relationship between Nasdaq Biotechnology etf current value and its past values and can show if there is a momentum factor associated with investing in Nasdaq Biotechnology Ishares.
 Regressed Prices 
Share
      Timeline 

Nasdaq Biotechnology Investors Sentiment

The influence of Nasdaq Biotechnology's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Nasdaq. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Nasdaq Biotechnology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Nasdaq Biotechnology's short interest history, or implied volatility extrapolated from Nasdaq Biotechnology options trading.

Current Sentiment - IBB

Nasdaq Biotechnology Investor Sentiment

Predominant part of Macroaxis users are currently bullish on Nasdaq Biotechnology Ishares. What is your trading attitude regarding investing in Nasdaq Biotechnology Ishares? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Nasdaq Biotechnology using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Nasdaq Biotechnology Hype Analysis, Nasdaq Biotechnology Correlation, Portfolio Optimization, Nasdaq Biotechnology Volatility, as well as analyze Nasdaq Biotechnology Alpha and Beta and Nasdaq Biotechnology Performance. Note that the Nasdaq Biotechnology information on this page should be used as a complementary analysis to other Nasdaq Biotechnology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Nasdaq Etf analysis

When running Nasdaq Biotechnology price analysis, check to measure Nasdaq Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nasdaq Biotechnology is operating at the current time. Most of Nasdaq Biotechnology's value examination focuses on studying past and present price action to predict the probability of Nasdaq Biotechnology's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nasdaq Biotechnology's price. Additionally, you may evaluate how the addition of Nasdaq Biotechnology to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Nasdaq Biotechnology technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Nasdaq Biotechnology technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Nasdaq Biotechnology trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...